MetaCap

QT Imaging Holdings Inc. (QTI)

NASDAQ: QTIHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

1.92+0.05 (+2.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

QTI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$28.21M
EPS (TTM)
-$0.91
52-week range
1.62 – 7.60
Day range
1.76 – 2.16
Volume / Avg
129.00K / 41.40K
Beta
—

52-week range

$1.62$7.60

QTI stock today

Shares of QT Imaging (QTI) finished higher on Nov 20 at $1.92, a gain of 2.67% or $0.05 per share, versus the S&P 500's 3.70% decline. Volume was 3.1x the average at 129.00K shares, a sign of unusually heavy trading. At this level, QTI sits near the bottom of its 52-week range of $1.62 to $7.60: 74.7% below the high, set on May 12, 2026 and 18.5% above the low.

QTI is down 68.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 69.3%. QT Imaging has posted a net loss over the last twelve months (EPS of -$0.91), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About QT Imaging

Company profile

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Dr. Raluca Dinu Ph.D.
Headquarters
Novato, CA
Employees
31

Financial highlights

Full financials

In fiscal 2025, QT Imaging generated $18.9 million in revenue, up 287.9% from fiscal 2024, its 2nd consecutive year of revenue growth. QT Imaging reported a net loss of $21.1 million, compared with a loss of $9.0 million a year earlier. Gross margin was 45.4% (down from 54.1%) and operating margin -23.4%.

QT Imaging annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$18.93M$4.88M$0$0
Growth+287.89%———
Net income$-21.08M$-8.98M$-6.10M$-2.77M
EPS (diluted)$-2.01$-2.13$-0.64$-0.60

Analyst forecast

Forecast

Consensus (3 analysts)

strong_buy

Avg. price target

$10.40+441.67%

  • Strong buy 0
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $8.00High $13.20

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 10, 2026
EPS actual vs est.
$-0.28 vs —

QTI news

All QTI news

QT Imaging peers

Health Care sector
QTI peer companies
CompanyPrice% ChgMarket capCompare
ECORelectroCore Inc.4.42-8.87%$40.78Mvs QTI
ITOCiTonic Holdings Ltd Class A1.59+6.00%$11.63Mvs QTI
POCIPrecision Optics Corporation Inc.4.12+1.41%$45.30Mvs QTI
IRIXIRIDEX Corporation0.4449-4.59%$7.92Mvs QTI
NDRAENDRA Life Sciences Inc.3.58-3.38%$5.36Mvs QTI
OMOutset Medical Inc.2.81-3.44%$53.03Mvs QTI
NUWENuwellis Inc.3.41-10.50%$1.84Mvs QTI
NXLNexalin Technology Inc.1.38-2.13%$1.71Mvs QTI

Indexes, lists and sector

QT Imaging stock FAQ

What is QT Imaging's stock price today?

QTI last traded at $1.92 as of Nov 20, 4:00 PM EST, up 2.67% on the day. Prices are delayed at least 15 minutes.

Does QT Imaging pay a dividend?

No. QT Imaging does not currently pay a regular cash dividend.

Who is QT Imaging's CEO?

Dr. Raluca Dinu Ph.D. is the chief executive officer of QT Imaging Holdings Inc., which has about 31 employees.

Has QTI ever split its stock?

Yes. The most recent QTI stock split was a 1-for-5 split on Oct 27, 2025, one of 2 splits on record.

What is the QTI 52-week high?

The 52-week high for QTI is $7.60 and the 52-week low is $1.62. The stock is currently 74.7% below its high.

Compare QTI